Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Viatris
Viatris
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Merck
Viatris
patents
diabetes
Januvia
Janumet
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
Endpoints
Mon, 02/13/23 - 10:02 pm
FDA
Biocon
Viatris
Avastin
biosimilars
drug manufacturing
AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort
Fierce Pharma
Fri, 12/16/22 - 11:08 am
AstraZeneca
Symbicort
patents
Viatris
EpiPen litigation comes back to haunt Teva a decade after initial settlements
Fierce Pharma
Tue, 12/6/22 - 10:50 am
EpiPens
Teva Pharmaceutical
legal
Viatris
NUVIGIL
Viatris executive charged in insider trading scheme that allegedly netted $7.2 million
Fierce Pharma
Sun, 11/13/22 - 06:55 pm
Viatris
insider trading
SEC
Viatris to buy two eye drug developers in deals worth up to $750M
BioPharma Dive
Mon, 11/7/22 - 05:29 pm
Viatris
M&A
Oyster Point Pharma
Famy Life Sciences
eye health
Viatris weighs sale of European consumer health business — report
Endpoints
Wed, 10/12/22 - 11:42 pm
Viatris
consumer health
Merck celebrates another win in Januvia patent battle against Viatris
Endpoints
Sun, 10/2/22 - 07:46 pm
Merck
Januvia
patents
legal
diabetes
Viatris
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Thu, 09/22/22 - 11:12 pm
Merck
Januvia
Janumet
generics
legal
Viatris
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
Fierce Pharma
Thu, 05/26/22 - 10:46 am
JNJ
Momenta Pharmaceuticals
Viatris
Copaxone
generics
drug manufacturing
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
M&A
AbbVie
Biocon
Biogen
Biohaven
GSK
Halozyme Therapeutics
Samsung Bioepis
UCB
Viatris
The mysterious case of Viatris and the missing insulin label deepens
Fierce Pharma
Wed, 04/13/22 - 10:42 am
Viatris
insulin
diabetes
biosimilars
Sanofi
Lantus
product recalls
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Viatris
AstraZeneca
generics
FDA
Symbicort
Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits
Fierce Pharma
Fri, 03/11/22 - 11:06 am
inflation
JNJ
Bayer
GSK
Viatris
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
Pharmaforum
Mon, 02/28/22 - 09:20 am
Biocon
India
Viatris
Mylan
biosimilars
M&A
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Fierce Pharma
Fri, 01/21/22 - 11:00 am
Viatris
diabetes
Semglee
insulin
generics
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort
Fierce Pharma
Tue, 12/14/21 - 11:33 pm
Viatris
generics
Symbicort
AstraZeneca
patents
COPD
asthma
Viatris launched two versions of its interchangeable insulin biosimilar. Why?
Fierce Pharma
Tue, 11/16/21 - 10:29 pm
Biocon
Viatris
Semglee
insulin
biosimilars
diabetes
Sanofi
Lantus
Viatris to close former Novartis site in California in January, lay off 75
Fierce Pharma
Tue, 10/12/21 - 11:07 am
drug manufacturing
layoffs
Viatris
Mylan
California
Pages
« first
‹ previous
1
2
3
next ›
last »